A new market study, titled “Global Bipolar Disorder Therapeutic Market Research Report 2018”, has been featured on WiseGuyReports.
This report studies the global Bipolar Disorder Therapeutic market status and forecast, categorizes the global Bipolar Disorder Therapeutic market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Bipolar disorder, also known as manic-depressive disorder, is a mental illness. It is a mental health problem that primarily affects mood. Symptoms of bipolar disorder are extreme irritability or agitation, a period of feeling empty, loss of interest in normal activities, sleep problems, etc. According to Pfizer, Inc., bipolar disorder affects over 5 million people in the U.S. Bipolar episodes are characterized by a drastic change in behavior and mood, and range from joyful and overexcited (manic episodes) to extremely sad and hopeless (depressive state). These disorders have different types of episodes such as manic episodes, hypomanic episodes, depressive episodes, and mixed episodes. Causes of bipolar disorders include childhood trauma, stressful life events, self-esteem problems, and genetic inheritance. People across the world marked “March 30” as a World Bipolar Day to spread awareness about the disorder and erase the stigma of mental illness. Large number of people suffering from this mental condition resort to drinking to lift their mood. According to the National Institute on Alcohol Abuse and Alcoholism, 27.6% of the people with bipolar disorder become addicted to alcohol, while over 16% engaged in alcohol abuse.
The growing need to reduce the financial burden of bipolar disorder will drive the growth prospects for the global bipolar disorder therapeutic market until the end of 2021. It has been observed that governments and companies across the globe are increasingly organizing awareness camps to raise disease awareness among the public, reduce the burden of mental disorders in vulnerable groups, ensure the rights of people with mental disorders, and make treatment facilities accessible to them. Consequently, such awareness initiatives help to curb the overall monetary loss, reduce their effect on the global economy, and improve the quality of life for patients. Such factors will raise public awareness about mental disorders and treatments and in turn, propel the rate of revenue generation in the market.
The Americas accounted for the majority market share during 2016 and will continue to dominate the market during the forecasted period. Some of the major factors responsible for the market’s growth in the region are the high incidence of bipolar disorder symptoms in the US, the growing number of pipeline products, the rising awareness about these disorders in the region, and the growing prevalence of pediatric bipolar disorders.
The major manufacturers covered in this report
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Allergan
Astellas Pharma
GlaxoSmithKline
Janssen Pharmaceuticals
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India
Request Sample Report at https://www.wiseguyreports.com/sample-request/3292020-global-bipolar-disorder-therapeutic-market-research-report-2018
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Antipsychotics
Anticonvulsants
Mood Stabilizers
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The study objectives of this report are:
To analyze and study the global Bipolar Disorder Therapeutic sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Bipolar Disorder Therapeutic manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Bipolar Disorder Therapeutic are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Bipolar Disorder Therapeutic Manufacturers
Bipolar Disorder Therapeutic Distributors/Traders/Wholesalers
Bipolar Disorder Therapeutic Subcomponent Manufacturers
Industry Association
Downstream Vendors
Table of Contents
1 Bipolar Disorder Therapeutic Market Overview
2 Global Bipolar Disorder Therapeutic Market Competition by Manufacturers
3 Global Bipolar Disorder Therapeutic Capacity, Production, Revenue (Value) by Region (2013-2018)
4 Global Bipolar Disorder Therapeutic Supply (Production), Consumption, Export, Import by Region (2013-2018)
5 Global Bipolar Disorder Therapeutic Production, Revenue (Value), Price Trend by Type
6 Global Bipolar Disorder Therapeutic Market Analysis by Application
7 Global Bipolar Disorder Therapeutic Manufacturers Profiles/Analysis
8 Bipolar Disorder Therapeutic Manufacturing Cost Analysis
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
11 Market Effect Factors Analysis
12 Global Bipolar Disorder Therapeutic Market Forecast (2018-2025)
13 Research Findings and Conclusion
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Your information will never be shared with any third party.